We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SPRB market cap is 61.88M. The company's latest EPS is USD -1.1343 and P/E is -1.34.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 1.96M | 2.17M |
| Operating Income | -11.88M | -11.56M | -12.11M | -13.2M | -13.97M |
| Net Income | -11.87M | -11.4M | -11.14M | -12.79M | -12.82M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.97M | -13.11M | -29.42M | -42.07M | -47.28M |
| Net Income | -9.86M | -13.09M | -29.54M | -42.29M | -46.18M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 104.52M | 95.3M | 85.65M | 139.11M | 125.96M |
| Total Liabilities | 15.39M | 16.82M | 17.16M | 31.12M | 29.4M |
| Total Equity | 89.12M | 78.48M | 68.49M | 108M | 96.56M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.78M | 4.69M | 162.88M | 126.49M | 85.65M |
| Total Liabilities | 2.71M | 7.52M | 13.46M | 15.12M | 17.16M |
| Total Equity | -17.8M | -30.64M | 149.43M | 111.37M | 68.49M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.37M | -29.95M | -41.68M | -11.79M | -9.8M |
| Investing | 26.02M | 9.12M | 23.69M | 10.48M | 32.48M |
| Financing | -187k | -277k | -241k | 50.53M | 50.1M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.57M | -12.62M | -27.52M | -35.88M | -41.68M |
| Investing | N/A | -4k | -74k | -79.17M | 23.69M |
| Financing | N/A | 12.43M | 181.04M | 643k | -241k |
| Market Cap | 61.88M |
| Price to Earnings Ratio | -1.34 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.53 |
| Price to Book Ratio | 0.9 |
| Dividend Yield | - |
| Shares Outstanding | 40.71M |
| Average Volume (1 week) | 77.01k |
| Average Volume (1 Month) | 139.95k |
| 52 Week Change | 34.51% |
| 52 Week High | 3.57 |
| 52 Week Low | 0.9547 |
| Spread (Intraday) | 0.09 (5.66%) |
| Company Name | Spruce Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sprucebiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
